CRH Medical Corp Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Net income
Depreciation of property, equipment and intangibles
Impairment of intangible asset
Stock-based compensation
Unrealized foreign exchange
Finance (income) expense
Income tax expense
Operating activity before changes in operating assets and liabilities
Taxes paid
Change in trade and other receivables
Change in prepaid expenses
Change in inventories
Change in trade and other payables
Change in employee benefits
Cash provided by operating activities
Proceeds from loans
Repayment of loans
Payment of interest on notes payable and bank indebtedness
Repayment of notes payable and bank indebtedness
Payment of financing fees
Operating activities:
Net income (loss)
Adjustments for:
Depreciation of property, equipment and intangibles
Stock-based compensation
Unrealized foreign exchange
Deferred income tax recovery
Change in fair value of contingent consideration
Accretion on contingent consideration and deferred consideration
Amortization of deferred financing fees
Loss on extinguishment of debt
Gain on equity investment
Impairment of intangible asset
Change in current tax receivable (payable)
Change in trade and other receivables
Change in prepaid expenses
Change in inventories
Change in trade and other payables, including contract payable
Change in employee benefits

Cash provided by operating activities
Financing activities
Proceeds from member loans
Repayment of member loans
Equity loan advance
Repayment of short-term advances
Repayment of notes payable and bank indebtedness
Proceeds on bank indebtedness
Payment of deferred financing fees
Payment of deferred consideration
Payment of earn-out obligation
Acquisition of equity interest from non-controlling interest
Distributions to non-controlling interest
Proceeds on settlement of derivative asset
Proceeds from the issuance of shares relating to stock-based compensation
Repurchase of shares for cancellation
Cash (used in) provided by financing activities
Acquisition of property and equipment
Acquisition of anesthesia services providers
Cash used in investing activities
Effects of foreign exchange on cash and cash equivalents
Increase in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Cash used in financing activities

Investing activities
Acquisition of property and equipment
Acquisition of anesthesia services providers
Deferred asset acquisition costs
Acquisition of equity interest from non-controlling interest
Acquisition of professional services agreements
Distribution received from equity investment
Purchase adjustment relating to anesthesia service providers acquired in prior periods
Cash used in investing activities
Acquisition of investment
Acquisition of equity investment
Effects of foreign exchange on cash and cash equivalents
Decrease in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental disclosure of cash interest and taxes paid:
Cash interest paid
Lease payments made
Non-cash acquisition financing
Taxes paid

Comments